MGX

MGX

Metagenomi Inc. Common Stock

$1.475+-0.000 (-0.000%)

실시간 가격

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$1.475

고가

$1.475

저가

$1.475

거래량

0.25M

기업 기본 정보

거래 통계

관련 뉴스

Analyst Upgrades

Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12

Chardan Capital analyst Geulah Livshits maintains Metagenomi with a Buy and lowers the price target from $13 to $12.

더 보기
Chardan Capital Maintains Buy on Metagenomi, Lowers Price Target to $12
Analyst Upgrades

Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $16

Wells Fargo analyst Yanan Zhu maintains Metagenomi with a Overweight and lowers the price target from $20 to $16.

더 보기
Wells Fargo Maintains Overweight on Metagenomi, Lowers Price Target to $16
GlobeNewswire

Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025

- Potential best-in-class extrahepatic in vivo gene editing with all-in-one delivery to the central nervous system (CNS) is a critical milestone for the treatment of neurological disorders - - Advancements demonstrate

더 보기
Metagenomi Presents Data Highlighting Advancements in Next-Generation Genome Editing Technologies at ASGCT Annual Meeting 2025
GlobeNewswire

Metagenomi to Present at Upcoming Scientific Meetings

EMERYVILLE, Calif., May 02, 2025 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (NASDAQ:MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing

더 보기
Metagenomi to Present at Upcoming Scientific Meetings